acetylleucyl-leucyl-norleucinal has been researched along with carmofur in 2 studies
| Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (carmofur) | Trials (carmofur) | Recent Studies (post-2010) (carmofur) |
|---|---|---|---|---|---|
| 321 | 0 | 53 | 254 | 46 | 45 |
| Protein | Taxonomy | acetylleucyl-leucyl-norleucinal (IC50) | carmofur (IC50) |
|---|---|---|---|
| Spike glycoprotein | Betacoronavirus England 1 | 1.82 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 1.82 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 1.82 | |
| Procathepsin L | Homo sapiens (human) | 1.82 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 1.82 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 1.82 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 1.82 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.5433 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 5 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 6.121 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 1.82 | |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.025 | |
| Acid ceramidase | Homo sapiens (human) | 0.3233 | |
| Acid ceramidase | Rattus norvegicus (Norway rat) | 0.029 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 1.82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, SA; Banerjee, S; Gayen, S; Ghosh, K; Jha, T | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
1 review(s) available for acetylleucyl-leucyl-norleucinal and carmofur
| Article | Year |
|---|---|
Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
Topics: Antiviral Agents; Catalytic Domain; Coronavirus 3C Proteases; Cysteine Proteinase Inhibitors; Drug Discovery; Drug Evaluation, Preclinical; Molecular Docking Simulation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; SARS-CoV-2 | 2021 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and carmofur
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |